194 related articles for article (PubMed ID: 16085360)
1. C3a expressed in the central nervous system protects against LPS-induced shock.
Boos L; Szalai AJ; Barnum SR
Neurosci Lett; 2005 Oct; 387(2):68-71. PubMed ID: 16085360
[TBL] [Abstract][Full Text] [Related]
2. Signaling through C5aR is not involved in basal neurogenesis.
Bogestål YR; Barnum SR; Smith PL; Mattisson V; Pekny M; Pekna M
J Neurosci Res; 2007 Oct; 85(13):2892-7. PubMed ID: 17551982
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the complement anaphylatoxin C3a receptor attenuates, whereas ectopic expression of C3a in the brain exacerbates, experimental autoimmune encephalomyelitis.
Boos L; Campbell IL; Ames R; Wetsel RA; Barnum SR
J Immunol; 2004 Oct; 173(7):4708-14. PubMed ID: 15383607
[TBL] [Abstract][Full Text] [Related]
4. Cutting edge: targeted disruption of the C3a receptor gene demonstrates a novel protective anti-inflammatory role for C3a in endotoxin-shock.
Kildsgaard J; Hollmann TJ; Matthews KW; Bian K; Murad F; Wetsel RA
J Immunol; 2000 Nov; 165(10):5406-9. PubMed ID: 11067891
[TBL] [Abstract][Full Text] [Related]
5. Expression of C5a in the brain does not exacerbate experimental autoimmune encephalomyelitis.
Reiman R; Campos Torres A; Martin BK; Ting JP; Campbell IL; Barnum SR
Neurosci Lett; 2005 Dec; 390(3):134-8. PubMed ID: 16154690
[TBL] [Abstract][Full Text] [Related]
6. A role for the C3a anaphylatoxin receptor in the effector phase of asthma.
Humbles AA; Lu B; Nilsson CA; Lilly C; Israel E; Fujiwara Y; Gerard NP; Gerard C
Nature; 2000 Aug; 406(6799):998-1001. PubMed ID: 10984054
[TBL] [Abstract][Full Text] [Related]
7. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6-aminonicotinamide.
Penkowa M; Quintana A; Carrasco J; Giralt M; Molinero A; Hidalgo J
J Neurosci Res; 2004 Jul; 77(1):35-53. PubMed ID: 15197737
[TBL] [Abstract][Full Text] [Related]
8. Complement: a novel factor in basal and ischemia-induced neurogenesis.
Rahpeymai Y; Hietala MA; Wilhelmsson U; Fotheringham A; Davies I; Nilsson AK; Zwirner J; Wetsel RA; Gerard C; Pekny M; Pekna M
EMBO J; 2006 Mar; 25(6):1364-74. PubMed ID: 16498410
[TBL] [Abstract][Full Text] [Related]
9. Astrocyte-specific expression of a soluble form of the murine complement control protein Crry confers demyelination protection in the cuprizone model.
Briggs DT; Martin CB; Ingersoll SA; Barnum SR; Martin BK
Glia; 2007 Nov; 55(14):1405-15. PubMed ID: 17674370
[TBL] [Abstract][Full Text] [Related]
10. The receptor for complement anaphylatoxin C3a is expressed by myeloid cells and nonmyeloid cells in inflamed human central nervous system: analysis in multiple sclerosis and bacterial meningitis.
Gasque P; Singhrao SK; Neal JW; Wang P; Sayah S; Fontaine M; Morgan BP
J Immunol; 1998 Apr; 160(7):3543-54. PubMed ID: 9531317
[TBL] [Abstract][Full Text] [Related]
11. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
[TBL] [Abstract][Full Text] [Related]
12. C3a receptor modulation of granulocyte infiltration after murine focal cerebral ischemia is reperfusion dependent.
Ducruet AF; Hassid BG; Mack WJ; Sosunov SA; Otten ML; Fusco DJ; Hickman ZL; Kim GH; Komotar RJ; Mocco J; Connolly ES
J Cereb Blood Flow Metab; 2008 May; 28(5):1048-58. PubMed ID: 18197178
[TBL] [Abstract][Full Text] [Related]
13. Central nervous system-targeted expression of the complement inhibitor sCrry prevents experimental allergic encephalomyelitis.
Davoust N; Nataf S; Reiman R; Holers MV; Campbell IL; Barnum SR
J Immunol; 1999 Dec; 163(12):6551-6. PubMed ID: 10586048
[TBL] [Abstract][Full Text] [Related]
14. Astrocyte-targeted expression of interleukin-6 protects the central nervous system during neuroglial degeneration induced by 6-aminonicotinamide.
Penkowa M; Camats J; Hadberg H; Quintana A; Rojas S; Giralt M; Molinero A; Campbell IL; Hidalgo J
J Neurosci Res; 2003 Aug; 73(4):481-96. PubMed ID: 12898533
[TBL] [Abstract][Full Text] [Related]
15. Use of monoclonal antibodies to assess expression of anaphylatoxin receptors in rat and murine models of lung inflammation.
Tschernig T; Kiafard Z; Dibbert C; Neumann D; Zwirner J
Exp Toxicol Pathol; 2007 Aug; 58(6):419-25. PubMed ID: 17544263
[TBL] [Abstract][Full Text] [Related]
16. Receptor for complement peptide C3a: a therapeutic target for neonatal hypoxic-ischemic brain injury.
Järlestedt K; Rousset CI; Ståhlberg A; Sourkova H; Atkins AL; Thornton C; Barnum SR; Wetsel RA; Dragunow M; Pekny M; Mallard C; Hagberg H; Pekna M
FASEB J; 2013 Sep; 27(9):3797-804. PubMed ID: 23737250
[TBL] [Abstract][Full Text] [Related]
17. Evolution of anaphylatoxins, their diversity and novel roles in innate immunity: insights from the study of fish complement.
Sunyer JO; Boshra H; Li J
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):77-89. PubMed ID: 16112742
[TBL] [Abstract][Full Text] [Related]
18. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
[TBL] [Abstract][Full Text] [Related]
19. Inflammation in central nervous system injury.
Allan SM; Rothwell NJ
Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
[TBL] [Abstract][Full Text] [Related]
20. Role of endothelial TLR4 for neutrophil recruitment into central nervous system microvessels in systemic inflammation.
Zhou H; Andonegui G; Wong CH; Kubes P
J Immunol; 2009 Oct; 183(8):5244-50. PubMed ID: 19786543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
